Status | Study |
Recruiting |
Study Name: Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors Condition: Adult Central Nervous System Germ Cell Tumor Adult Ependymoblastoma Date: 2009-09-23 Interventions: Drug: Carboplatin Given IA |
Completed |
Study Name: ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Germ Cell Tumor Date: 2009-07-24 Interventions: Drug: veliparib Given PO |
Active, not recruiting |
Study Name: Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma Condition: Brain and Central Nervous System Tumors Lymphoma Neuroblas Date: 2009-07-14 Interventions: Drug: crizotinib Other: pharmacogenomic st |
Completed |
Study Name: Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial Condition: Brain and Central Nervous System Tumors Leukemia Unspecifi Date: 2009-04-28 Interventions: Other: questionnaire administration Proced |
Active, not recruiting |
Study Name: Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System Condition: Untreated Childhood Medulloblastoma Untreated Childhood Pineoblastoma Date: 2009-03-20 Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy |
Active, not recruiting |
Study Name: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor Condition: Solid Tumor Adult Central Nervous System Germ Cell Tumor A Date: 2008-03-18 Interventions: Drug: busulfan Given IV |
Active, not recruiting |
Study Name: Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma Condition: Brain and Central Nervous System Tumors Date: 2008-01-10 Interventions: Drug: Induction Chemotherapy A |
Active, not recruiting |
Study Name: Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Condition: Brain and Central Nervous System Tumors Intraocular Melanoma Date: 2007-03-07 Interventions: Genetic: DNA analysis Other: immunologic t |
Recruiting |
Study Name: Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma Condition: Untreated Childhood Medulloblastoma Untreated Childhood Pineoblastoma Date: 2006-10-25 Interventions: Radiation: Radiation Therapy U |
Completed |
Study Name: AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Germ Cell Tumor Date: 2006-05-16 Interventions: Drug: Cediranib Maleate Given orally Other Names: |